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and other gram-negative pathogens in Europe (8-
10) underlines the need for systematic surveil-
lance to monitor the spread of similar resistance
determinants.
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Malaria and Global Warming
in Perspective?
To the Editor: I read with great interest the
article “From Shakespeare to Defoe: malaria in
England in the Little Ice Age” (1). Unfortunately,
the article is not as balanced as a presentation
last year by Paul Reiter, which clearly illustrated
that, although climate is important in the
transmission of malaria, the influence of other
factors (e.g., access to medical care and improved
housing) is likely to be of more importance in
Europe.
Malaria indeed was quite common in Europe,
even in the Roman Empire and in Medieval
Europe, and until a few decades ago, it was still
present in parts of Europe, Australia, and North
America. In fact, the failure of the 1806 British
invasion of Zeeland in the Netherlands may be
attributable to infection of the British forces with
malaria. However, the authors referenced by
Reiter have never made the claim that in the
coming years warmer “temperatures will result
in malaria transmission in Europe and North
America.” On the contrary, the reports of the
Intergovernmental Panel on Climate Change
Reiter quotes conclude that “Although climate
change could increase the potential transmission
of malaria [in Europe and North America],
existing public health resources—disease sur-
veillance, surface water management, and
treatment of cases—would make reemergent
malaria unlikely” (2,3).
Reiter’s argument that some scientists
attribute the recent observed increase in malaria
risk to climate trends is also not accurate. While
acknowledging the sensitivity of the malaria
mosquito and parasite to climate, these research-
ers examine insect and incidence data to explore
multiple factors underlying malaria emergence.
Another group of scientists uses mathematical
simulation models to estimate changes in
malaria risk over the next few decades. These
models, which are heuristic tools not meant to
predict future worlds, assess how potential risk
for malaria may by affected by changes in
climate (4). The goals of both types of research
are to improve knowledge of the complex malaria
transmission cycle, define epidemic-prone areas,
identify the reasons for increased malaria risk,
and develop solutions to protect vulnerable
communities.Letters Letters Letters Letters Letters
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Dr. Reiter acknowledges the sensitivity of
malaria to climatic influences, and I am sure that
he agrees that change in climate will affect risk
for transmission—he may be skeptical as to
whether global warming will ever become a fact,
but that is another question. While Reiter’s paper
offers an interesting perspective on the history of
malaria in Europe, it provides no illuminating
information on the influence of climate change on
human health.
Pim Martens Pim Martens Pim Martens Pim Martens Pim Martens
Maastricht University, Maastricht, the Netherlands
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For P. Reiter’s response, please see
http://www.cdc.gov/ncidod/EID/vol6no4/reiter.htm
Serologic Evidence of Human Monocytic
and Granulocytic Ehrlichiosis in Israel
To the Editor: : : : : We read with great attention the
article by Dr. Keysary et al., who reported the
first evidence of human monocytic and granulo-
cytic ehrlichiosis in Israel (1); however, we
disagree with their conclusions.
Ehrlichiae comprise a large group of
intracellular organisms pathogenic for animals
and occasionally for humans. Because these
organisms are closely related, serologic cross-
reactions occur within and between groups,
leading to mistakes in identification. For
example,  Ehrlichia chaffeensis was misdiag-
nosed as E. canis in humans (2) and human
granulocytic ehrlichiosis as human monocytic
ehrlichiosis in areas where the vector was not
present (3). Because of such cross-reactions,
serology alone is not sufficient to establish the
existence of a new ehrlichial disease.
With the exception of Rhipicephalus
sanguineus, the brown dog tick, which is
distributed worldwide, tick species of medical
importance are very geographically specific. For
example, the Ixodes and Dermacentor spp. found
in Europe are not those found in the United
States. Consequently, tick-transmitted organ-
isms and diseases are also very specific
geographically. For example, Borrelia spp. found
in the Old World are not found in America (except
for B. burgdorferi stricto sensu, which is found in
both Europe and America). R. rickettsii,
transmitted by Dermacentor andersoni and
D. variablilis, is reported in the United States but
not in Europe, where the vectors are not present.
American monocytic ehrlichiosis is caused by
E. chaffeensis, which is transmitted by the tick
Amblyomma americanum, found only in America.
The main reservoir is the deer Odocoileus
virginanus (4).
It is very unlikely that a tick-borne disease
occurred in a country where neither the vector
nor the reservoir of the bacterium exists. All
attempts to demonstrate the presence of
E. chaffeensis in the Old World, including Africa,
have failed. Indeed, there is no convincing
evidence of the existence of E. chaffeensis outside
America.
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